Sorin Group Announces Purchase of the Cannulae Activities from Its Supplier Bioengineering Laboratories

Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the purchase of cardiac surgery cannulae manufacturing activities from its supplier Bioengineering Laboratories S.p.A. ("BEL”) located in Cantù (Como), Italy.

BEL develops, manufactures and distributes disposable medical devices for urology, urodynamics, heart surgery and haemodialysis. The transaction relates to BEL’s manufacturing activities of cardiac surgery cannulae, which the company was producing on an exclusive basis for Sorin Group. These cannulae are an integral part of Sorin Group cannulae offering and generated revenues of around €4 million in 2013.

After the acquisitions of the Estech minimally invasive cannulae product line in 2011 and the CalMed product line in 2012, this acquisition represents a further step in Sorin’s strategy of strengthening its global position in this market segment.

"This deal confirms Sorin Group’s commitment to further strengthen our presence in the cannulae segment and consolidate our relationship with cardiac surgeons and clinical perfusionists worldwide,” said Michel Darnaud, President, Cardiac Surgery Business Unit, Sorin Group.

About Sorin Group

Sorin Group (Reuters Code: SORN.MI), is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,750 employees worldwide, the Company focuses on two major therapeutic areas: Cardiac Surgery (cardiopulmonary products for open heart surgery and heart valve repair or replacement products) and Cardiac Rhythm Management (pacemakers, defibrillators, cardiac resynchronization devices). Every year, over one million patients are treated with Sorin Group devices in more than 80 countries.

For more information, please refer to www.sorin.com.